admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

MindMed Announces Pricing of Public Offering of Common Shares and Warrants

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of...

MindMed Announces Proposed Public Offering of Common Shares

BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives

atai Life Sciences Announces Initiation of Phase 1 Trial for its...

PT359 – Sawyer Hurwitz – Art, Philosophy, Sexuality, and “Psychedelics Tonight”

Psilocybin in the Treatment of Alcohol Use Disorder

Clearmind Announces Notice of Proposed Stock Consolidation

MYDECINE INNOVATIONS GROUP ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT AND WELCOMES...

1...116117118...218 Page 117 of 218

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin